800-Patient study aims to unlock secrets of autoimmune liver disease
NCT ID NCT07594990
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This French study will collect medical data and biological samples from 800 people with autoimmune liver diseases. Researchers hope to identify new markers that explain why some patients respond well to treatment while others do not. The goal is to better understand the immune mechanisms behind these diseases, which could eventually lead to more effective treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal why some patients respond to treatment and others do not, pointing toward more personalized therapies for autoimmune liver diseases.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly test any new drug or cure, and results may take years to translate into clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE LIVER DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AP-HP Beaujon
Clichy, France
-
AP-HP Paul Brousse
Villejuif, France
-
AP-HP Saint-Antoine
Paris, France
-
CHD Vendée
La Roche-sur-Yon, France
-
CHU Nantes
Nantes, France
-
CHU Poitiers
Poitiers, France
-
CHU d'Angers
Angers, France
-
CHU de Brest
Brest, France
-
CHU de Lille
Lille, France
-
CHU de Rennes
Rennes, France
-
CHU de Toulouse
Toulouse, France
-
CHU de Tours
Tours, France
-
Hospices Civils de Lyon
Lyon, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Artificial intelligence may help decide who gets a liver first
- AI may outsmart current system for liver transplant priority
- Can a smartwatch help manage a rare liver disease? stanford study investigates
- New study tracks blood sugar in liver disease patients on common drug
- Promising new treatment for rare liver disease shows potential in Late-Stage trial
- Austrian PBC registry aims to unlock secrets of rare liver disease